G Medical Innovations Holdings Ltd
Change company Symbol lookup
Select an option...
GMVD G Medical Innovations Holdings Ltd
CMPX Compass Therapeutics Inc.
AMST Amesite Inc
AMPX Amprius Technologies Inc
PRTK Paratek Pharmaceuticals Inc
EGRAY Energy Resources Of Australia Ltd
IVAC Intevac Inc
PFE Pfizer Inc
BNOX Bionomics Ltd
CRKN Crown Electrokinetics Corp.
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Providers & Services | Small Cap Value
Based in Cayman Islands
Company profile

G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.

Closing Price
$0.91
Day's Change
-0.75 (-45.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.13
Day's Low
0.89
Volume
(Heavy Day)
Volume:
14,375,129

10-day average volume:
1,803,160
14,375,129

CTXS, GAIA & DAKT Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate

11:13 am ET January 11, 2023 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / January 11, 2023 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Law Clerk and Client Relations Manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Bronstein, Gewirtz and Grossman, LLC, Wednesday, January 11, 2023, Press release picture

Citrix Systems, Inc. (NASDAQ:CTXS)

Class Period: Citrix common stock held as of the close of business on September 30, 2022 ("Class Period") through current

Deadline: February 13, 2023

For more info: www.bgandg.com/ctxs

The complaint alleges the Board deliberately used false projections to conceal the true value of Citrix from Citrix shareholders and thereby secured the approval of such shareholders to sell Citrix to Vista Equity Partners ("Vista") and Elliott Investment Management L.P. ("Elliott") for the inadequate and unfair price of $104.00 per share in cash ("Merger Consideration"), pursuant to a merger ("Merger") under which Citrix became a wholly-owned subsidiary of TIBCO Software, Inc. ("TIBCO"), a portfolio company of Vista. The Complaint continues to allege that the false and misleading Proxy authorized by defendants caused the consummation of the Merger at an unfair price per share that did not adequately value Citrix and thus caused economic harm to Citrix, who were forced to sell their shares to Elliott and Citrix at an unfair and inadequate price.

Gaia, Inc. (NASDAQ:GAIA)

Class Period: December 26, 2017 - November 7, 2022

Deadline: February 21, 2023

For more info: www.bgandg.com/gaia

The complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose, among other things, that: (1) the Company's first quarter 2019 subscriber count was overstated; (2) the Company lacked adequate internal controls; (3) as a result, defendants had a heightened risk of regularly scrutiny and ultimately subject to an SEC investigation and action; and (4) as a result of the foregoing, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the truth emerged, the lawsuit claims that investors suffered damages.

Daktronics, Inc. (NASDAQ:DAKT)

Class Period: March 10, 2022 - December 6, 2022

Deadline: February 21, 2023

For more info: www.bgandg.com/dakt

The complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company was experiencing challenges that increased costs, including supply chain disruptions, that impacted Daktronics' ability to fund inventory levels and operations; (2) that, as a result, it was probable that some portion of the Company's deferred tax assets would not be realized; (3) that as a result, Daktronics was reasonably likely to record a material valuation allowance to its deferred tax assets; (4) that there were material weaknesses in the Company's internal controls over financial reporting related to income taxes; (5) that the foregoing presented liquidity concerns and there was substantial doubt as to the Company's ability to continue as a going concern; (6) as a result, Defendants' statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Nathanson

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC





View source version on accesswire.com:

https://www.accesswire.com/733845/CTXS-GAIA-DAKT-Class-Action-Reminders-Bronstein-Gewirtz-Grossman-LLC-A-Successful-Firm-Reminds-Investors-of-Deadlines-and-to-Actively-Participate



comtex tracking

COMTEX_422483187/2457/2023-01-11T11:13:13

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.